These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8616025)

  • 1. Comparison of myeloma cell contamination of bone marrow and peripheral blood stem cell harvests.
    Henry JM; Sykes PJ; Brisco MJ; To LB; Juttner CA; Morley AA
    Br J Haematol; 1996 Mar; 92(3):614-9. PubMed ID: 8616025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.
    Lemoli RM; Cavo M; Fortuna A
    J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative comparison of multiple myeloma tumor contamination in bone marrow harvest and leukapheresis autografts.
    Vescio RA; Han EJ; Schiller GJ; Lee JC; Wu CH; Cao J; Shin J; Kim A; Lichtenstein AK; Berenson JR
    Bone Marrow Transplant; 1996 Jul; 18(1):103-10. PubMed ID: 8832002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric DNA quantification in immunophenotyped cells as a sensitive method for determination of aneuploid multiple myeloma cells in peripheral blood stem cell harvests and bone marrow after therapy.
    Nowak R; Oelschlägel U; Range U; Bergmann S; Bornhäuser M; Hölig C; Schuler U; Krebs U; Günther H; Kroschinsky F; Ehninger G
    Bone Marrow Transplant; 1999 May; 23(9):895-900. PubMed ID: 10338044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose sequential chemoradiotherapy in multiple myeloma: residual tumor cells are detectable in bone marrow and peripheral blood cell harvests and after autografting.
    Corradini P; Voena C; Astolfi M; Ladetto M; Tarella C; Boccadoro M; Pileri A
    Blood; 1995 Mar; 85(6):1596-602. PubMed ID: 7888677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-time polymerase chain reaction in multiple myeloma: quantitative analysis of tumor contamination of stem cell harvests.
    Ladetto M; Omedè P; Sametti S; Donovan JW; Astolfi M; Drandi D; Volpato F; Giaccone L; Giaretta F; Palumbo A; Bruno B; Pileri A; Gribben JG; Boccadoro M
    Exp Hematol; 2002 Jun; 30(6):529-36. PubMed ID: 12063019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engraftment of gene-marked hematopoietic progenitors in myeloma patients after transplant of autologous long-term marrow cultures.
    Stewart AK; Sutherland DR; Nanji S; Zhao Y; Lutzko C; Nayar R; Peck B; Ruedy C; McGarrity G; Tisdale J; Dubé ID
    Hum Gene Ther; 1999 Aug; 10(12):1953-64. PubMed ID: 10466629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
    Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
    Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of chemotherapy on the mobilisation, harvest and economic costs of autologous peripheral stem cell transplantation in patients with multiple myeloma.
    Jerjis S; Croockewit S; Preijers F; Schaap N; De Witte T
    Leuk Lymphoma; 2000 May; 37(5-6):551-60. PubMed ID: 11042515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mobilization of circulating hematopoietic stem cells by granulocyte colony stimulating factor after chemotherapy in multiple myeloma].
    Ohler L; Scholten C; Reiter E; Tiefengraber E; Jäger U; Strobl H; Lechner K; Höcker P; Geissler K
    Wien Klin Wochenschr; 1993; 105(20):580-4. PubMed ID: 7505076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunophenotypic analysis of peripheral blood stem cell harvests from patients with multiple myeloma.
    Mateo G; Corral M; Almeida J; López-Berges C; Nieto mJ; García-Marcos A; Vázquez L; del Cañizo C; Orfao A; San Miguel JF
    Haematologica; 2003 Sep; 88(9):1013-21. PubMed ID: 12969809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of high-dose therapy and autologous transplantation in non-Hodgkin's lymphoma based on the presence of tumor in the marrow or infused hematopoietic harvest.
    Sharp JG; Kessinger A; Mann S; Crouse DA; Armitage JO; Bierman P; Weisenburger DD
    J Clin Oncol; 1996 Jan; 14(1):214-9. PubMed ID: 8558200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD34 selections from myeloma peripheral blood cell autografts contain residual tumour cells due to impurity, not to CD34+ myeloma cells.
    Willems P; Croockewit A; Raymakers R; Holdrinet R; van Der Bosch G; Huys E; Mensink E
    Br J Haematol; 1996 Jun; 93(3):613-22. PubMed ID: 8652382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple myeloma: the number of reinfused plasma cells does not influence outcome of patients treated with intensified chemotherapy and PBPC support.
    Boccadoro M; Omedé P; Dominietto A; Palumbo A; Bringhen S; Giaretta F; Ortolano B; Triolo S; Pileri A
    Bone Marrow Transplant; 2000 Jan; 25(1):25-9. PubMed ID: 10654010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular detection of clonally rearranged cells in peripheral blood progenitor cell harvests from multiple myeloma patients.
    Bird JM; Bloxham D; Samson D; Marcus RE; Russell NH; Kelsey SM; Newland AC; Apperley JF
    Br J Haematol; 1994 Sep; 88(1):110-6. PubMed ID: 7803232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linear reduction of clonal cells in stem cell enriched grafts in transplanted multiple myeloma.
    Thunberg U; Bånghagen M; Bengtsson M; Christensen LD; Geisler CH; Gimsing P; Lenhoff S; Mortensen BT; Olofsson T; Simonsson B; Andersen NS; Sundström C; Swedin A; Sällström JF; Thuresson B; Westin J; Carlson K
    Br J Haematol; 1999 Mar; 104(3):546-52. PubMed ID: 10086793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential analysis of bone marrow and peripheral blood after stem cell transplant for myeloma shows disparate tumor involvement.
    Billadeau D; Prosper F; Verfaillie C; Weisdorf D; Van Ness B
    Leukemia; 1997 Sep; 11(9):1565-70. PubMed ID: 9305613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of granulocyte colony-stimulating factor (G-CSF) for mobilizing peripheral blood stem cells: risk of mobilizing clonal myeloma cells in patients with bone marrow infiltration.
    Vora AJ; Toh CH; Peel J; Greaves M
    Br J Haematol; 1994 Jan; 86(1):180-2. PubMed ID: 7516696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral blood stem cell contamination evaluated by a highly sensitive molecular method fails to predict outcome of autotransplanted multiple myeloma patients.
    Galimberti S; Morabito F; Guerrini F; Palumbo GA; Azzará A; Martino M; Benedetti E; Di Raimondo F; Petrini M
    Br J Haematol; 2003 Feb; 120(3):405-12. PubMed ID: 12580954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous peripheral blood progenitor cell transplantation for multiple myeloma.
    Attal M; Harousseau JL
    Baillieres Best Pract Res Clin Haematol; 1999; 12(1-2):171-91. PubMed ID: 11000991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.